Synergistic activity of troxacitabine (Troxatyl™) and gemcitabine in pancreatic cancer

BACKGROUND: Gemcitabine, a deoxycytidine nucleoside analog, is the current standard chemotherapy used as first-line treatment for patients with locally advanced or metastatic cancer of the pancreas, and extends life survival by 5.7 months. Advanced pancreatic cancer thus remains a highly unmet medic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Damaraju, Vijaya L, Bouffard, David Y, Wong, Clarence KW, Clarke, Marilyn L, Mackey, John R, Leblond, Lorraine, Cass, Carol E, Grey, Mike, Gourdeau, Henriette
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2007
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1948004/
https://ncbi.nlm.nih.gov/pubmed/17608948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-7-121
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars